UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046467
Receipt number R000053017
Scientific Title Examination of changes in muscle quality in patients with acute stroke patients and factors that influence the changes
Date of disclosure of the study information 2022/01/01
Last modified on 2024/06/28 12:09:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Changes in muscle quality in patients with acute stroke patients and assessment of factors that influence the changes

Acronym

Relationship between stroke and muscle quality

Scientific Title

Examination of changes in muscle quality in patients with acute stroke patients and factors that influence the changes

Scientific Title:Acronym

Relationship between stroke and muscle quality

Region

Japan


Condition

Condition

stroke

Classification by specialty

Neurology Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The change in muscle quality in the acute elderly stroke patients has been evaluated by the Phase Angle (PA) that can be measured by a body composition analyzer using the BIA method, and the factors that influence the change in PA are analyzed.

Basic objectives2

Others

Basic objectives -Others

It has become clear that measurement of muscle quality by a body composition analyzer using the bioelectrical impedance method is effective. According to the applicant's examination so far, the muscle quality of elderly stroke patients was significantly lower than that of healthy subjects during the recovery period, and the value had a strong influence on ADL recovery. It was thought that if the deterioration of muscle quality in the acute phase could be prevented, the recovery of ADL in the convalescent phase could be promoted more smoothly. In this study, we will clarify the preventive method for muscle deterioration in the acute phase of stroke by analyzing the changes in muscle quality in the acute phase of elderly stroke patients and the factors that influence the deterioration.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Stroke Severity (NIHSS), Dietary Content, Energy Intake, Amount of protein intake, Skeletal muscle mass, PA value, TP, Alb, mass of masseter muscle

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Stroke patients who were admitted to the stroke care unit and received rehabilitation treatment.

Key exclusion criteria

Patients with a pacemaker

Target sample size

154


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Irisawa

Organization

Dokkyo Medical University

Division name

Department of Rehabilitation Medicine

Zip code

3210293

Address

880, Kitakobayashi, Mibu, Shimotuga, Tochigi

TEL

+81282872170

Email

irisawah@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Irisawa

Organization

Dokkyo Medical University

Division name

Department of Rehabilitation Medicine

Zip code

3210293

Address

880, Kitakobayashi, Mibu, Shimotsuga

TEL

+81282872170

Homepage URL


Email

irisawah@dokkyomed.ac.jp


Sponsor or person

Institute

Department of Rehabilitation Medicine, Dokkyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Dokkyo Medical University Clinical Research Management Center

Address

880, Kitakobayasshi, Mibu, Shimotsuga, Tochigi

Tel

0282-87-2275

Email

r-kenkyu@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

獨協医科大学(栃木県)


Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

166

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 08 Month 01 Day

Date of IRB

2021 Year 09 Month 24 Day

Anticipated trial start date

2022 Year 01 Month 01 Day

Last follow-up date

2023 Year 10 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete

2024 Year 03 Month 31 Day

Date analysis concluded

2024 Year 10 Month 31 Day


Other

Other related information

Research has ended. Currently being analyzed.


Management information

Registered date

2021 Year 12 Month 24 Day

Last modified on

2024 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053017